Arkansas Research Trials
Clinical research site in North Little Rock, Arkansas
As of July 2026, 4 paid clinical trials are recruiting at Arkansas Research Trials in North Little Rock, Arkansas. Active studies at this site cover conditions such as Atopic Dermatitis, Eczema and Cutaneous Squamous Cell Carcinoma (CSCC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Arkansas Research Trials (4)
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Get new-trial alerts for Arkansas Research Trials
We'll email you whenever a new clinical trial starts recruiting at this research site in North Little Rock, AR. Unsubscribe anytime.
More research sites in North Little Rock
- 89bio Clinical Study Site (2 trials)
- Akero Clinical Study Site (2 trials)
- Arkansas Gastroenterology - North Little Rock (2 trials)
- Altimmune Clinical Study Site (1 trial)
- Arkansas Dermatology - North Little Rock (1 trial)
- Arkansas Surg Hosp (1 trial)
- CHI St. Vincent Heart Institute (1 trial)
- Central Arkansas Radiation Therapy Institute, dba CARTI (1 trial)
- Central Arkansas Veterans Healthcare System (3J/NLR) (1 trial)
- Leo Pharma Investigational site (1 trial)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in North Little Rock, AR · Arkansas clinical trials